Benign prostatic hyperplasia: clinical features and diagnosis
For older men, benign prostatic hyperplasia is a common cause of lower urinary tract symptoms such as polyuria, incomplete bladder emptying, urinary urgency and, in severe cases, urinary retention
The prostate is a doughnut-shaped gland that is located below the bladder, encircling the male urethra. Its function is to secrete prostatic fluid, which constitutes about 25% of semen. Benign prostatic hyperplasia (BPH) — a condition in which the prostate gland is enlarged — affects around 50% of men over the age of 60 years.
BPH can be asymptomatic, but for many men it is associated with lower
urinary tract symptoms. Symptoms can be associated with difficulties
storing urine (eg, urinary urgency and polyuria) or voiding the bladder (eg,
urinary hesitancy and poor urinary flow). Investigations for men with BPH
include measurement of serum prostate specific antigen, digital rectal
examination and prostate ultrasound or biopsy.
Andrew Husband is principal lecturer for pharmacy practice and clinical therapeutics and Adam Todd is senior lecturer for pharmacy practice and clinical therapeutics, both at the University of Sunderland.
Citation: Clinical Pharmacist URI: 11094166
Recommended from Pharmaceutical Press
All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.£54.00
Now in its twelfth edition, Stockley’s Drug Interactions is still the most comprehensive and authoritative international source of drug interaction information.£240.00
Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.£54.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.£48.00
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.£40.00